Back to top
more

Veeva Systems (VEEV)

(Delayed Data from NYSE)

$223.39 USD

223.39
1,213,304

+6.94 (3.21%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $242.40 +19.01 (8.51%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 251)

Industry: Internet - Software

Zacks News

Sweta Jaiswal headshot

4 Medical Device Stocks That More Than Doubled in 2018

Here are four medical device stocks which have performed really well in 2018 and should be on investors' radar next year as well.

Hologic's (HOLX) New Offering to Revitalize Cynosure Division

The latest launch along with certain new developments is expected to boost top-line contribution from Hologic's (HOLX) Cynosure division in the near term.

Bruker Profits from NANO & CALID, New Buyout Holds Promise

Bruker (BRKR) looks to gain from high demand for ADVANCE X-ray and nano-analysis products. The CALID Group also raises hope with high-single digit robust year-to-date revenues.

Veeva Systems (VEEV) Gains As Market Dips: What You Should Know

Veeva Systems (VEEV) closed the most recent trading day at $92.13, moving +0.1% from the previous trading session.

Thermo Fisher (TMO) Rides on New Buyouts and APAC Strength

We are upbeat about Thermo Fisher's (TMO) recent buyout of Advanced Bioprocessing business, which will add complementary cell culture products to the company's bioproduction suit.

Edwards Lifesciences Advances in AI With Bay Labs Tie-Up

Through the tie-up, Edwards Lifesciences (EW) aims at improving detection of heart diseases and enhancing quality by using Bay Labs' ability to apply AI to cardiovascular imaging.

CVS Health Aetna Synergy Impressive, PBM Selling Season Solid

CVS Health (CVS) estimates a $750-million earning from near-term synergies with low- to mid-single digit addition in the second year after the closure of Aetna transaction.

STERIS Rides on Favorable Industry Trends, Rivalry a Concern

STERIS (STE) is currently displaying strong top-line growth on encouraging market trends along with a new product and service portfolio.

NuVasive's Monolith Corpectomy System Ok'd for Expanded Use

NuVasive's (NUVA) latest FDA 510 (k) clearance receipt is expected to augment customer base and market reach.

Hologic Unveils Omni Hysteroscope, Boosts GYN Surgical Arm

Hologic (HOLX) highlights that a direct visualization of the uterine cavity in women with abnormal uterine bleeding will set a benchmark for the medical test.

Hill-Rom Adds New Capabilities to Centrella Smart+ Beds

Hill-Rom (HRC) stays focused on expansion through product development. The latest move is expected to boost the top-line results of the company.

Here's Why You Should Buy Myriad Genetics (MYGN) Stock Now

Myriad Genetics (MYGN) see strong testing volumes from new products.

Insulet Gains on Omnipod Reimbursement Update, Rivalry Stiff

Insulet Corporation (PODD) continues to expand Omnipod's market access on growing reimbursements. The company operates in a highly competitive environment.

Myriad Genetics Announces Encouraging EndoPredict Test Data

Myriad Genetics (MYGN) forges ahead with initiatives to boost the adoption of the EndoPredict tests.

Illumina (ILMN) Takes Part in NIH Program With Genotype Launch

The new Infinium Global Diversity Array of Illumina (ILMN) will process up to 1 million cost-free samples to the three genome centers.

Has Veeva Systems (VEEV) Outpaced Other Computer and Technology Stocks This Year?

Is (VEEV) Outperforming Other Computer and Technology Stocks This Year?

QIAGEN Partners With Novartis to Expand CDx Tests Suite

QIAGEN (QGEN) progresses well with the strategy to expand through strategic collaborations. The latest tie up will boost the company's companion diagnostic portfolio.

Time to Focus on Veeva Systems (VEEV) for Strong Earnings Growth Potential

Veeva Systems (VEEV) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

Quest Diagnostics Rides on Product Launches, Strategic Deals

Quest Diagnostics' (DGX) consistent efforts to refocus on core diagnostic information services business and disciplined capital deployment buoy optimism on the stock.

STERIS (STE) Dips on New Restructuring Plan, Layoff Decision

STERIS (STE) aims to stop the production of the worst-hit products and move toward the existing manufacturing operations by fiscal 2020.

Veeva Systems Announces New DAM Solution for Life Sciences

Veeva Vault Digital Publishing uses Veeva Systems' (VEEV) flagship Vault PromoMats or Vault MedComms platforms for updating digital content. The platform leverages on Amazon CloudFront.

Here's Why You Should Invest in Veeva Systems (VEEV) Now

A solid fiscal third quarter and a plethora of recent developments make Veeva Systems (VEEV) a promising investment pick.

Here's Why You Should Invest in Chemed (CHE) Stock Right Now

Chemed's (CHE) subsidiaries continue to register strong sales.

ResMed to Buy Propeller Health, Widens Respiratory Care Suite

Post the acquisition, Propeller will continue to operate as an independent entity within ResMed's (RMD) Respiratory Care suite.

Chemed Grows on Robust VITAS & Roto-Rooter Despite Headwinds

Chemed's (CHE) Roto-Rooter business is showing a marked improvement on solid segmental performances at the core plumbing and drain cleaning service plus a strong uptick in water restoration.